(2S,3R,5S)-5-[(N-Formyl-L-leucyl)oxy]-2-hexyl-3-hydroxyhexadecanoic Acid (Orlistat Impurity)
|
|
- CAS-Nr.
- 130793-28-1
- Englisch Name:
- (2S,3R,5S)-5-[(N-Formyl-L-leucyl)oxy]-2-hexyl-3-hydroxyhexadecanoic Acid (Orlistat Impurity)
- Synonyma:
- Orlistat Impurity;Orlistat Impurity 26;Orlistat open ring epimer;orlistat open ring epimer impurity;Orlistat Open Ring (2S,3R,5S)-Isomer;(2S,3R,5S)-Orlistat Open Ring Impurity;Orlistat Open Ring Impurity (2S,3R,5S)-Isomer;Orlistat Impurity 38 (Orlistat Open Ring Epimer);Orlistat USP Related Compound (Orlistat open ring epimer);Orlistat Impurity 38 (orlistat open-loop differential isomer)
- CBNumber:
- CB52129508
- Summenformel:
- C29H55NO6
- Molgewicht:
- 513.75
- MOL-Datei:
- 130793-28-1.mol
|
(2S,3R,5S)-5-[(N-Formyl-L-leucyl)oxy]-2-hexyl-3-hydroxyhexadecanoic Acid (Orlistat Impurity) Eigenschaften
- Siedepunkt:
- 645.8±55.0 °C(Predicted)
- Dichte
- 1.005±0.06 g/cm3(Predicted)
- storage temp.
- -86°C Freezer, Under Inert Atmosphere
- Löslichkeit
- Chloroform (Slightly), DMSO (Slightly), Methanol (Slightly)
- Aggregatzustand
- Solid
- pka
- 4.37±0.50(Predicted)
- Farbe
- Colourless
- Stabilität:
- Temperature Sensitive
Sicherheit
(2S,3R,5S)-5-[(N-Formyl-L-leucyl)oxy]-2-hexyl-3-hydroxyhexadecanoic Acid (Orlistat Impurity) Chemische Eigenschaften,Einsatz,Produktion Methoden
Chemische Eigenschaften
Clear Light Yellow Viscous Oil
Verwenden
A product from thermal and hydrolytic degradation
(2S,3R,5S)-5-[(N-Formyl-L-leucyl)oxy]-2-hexyl-3-hydroxyhexadecanoic Acid (Orlistat Impurity) Upstream-Materialien And Downstream Produkte
Upstream-Materialien
Downstream Produkte
(2S,3R,5S)-5-[(N-Formyl-L-leucyl)oxy]-2-hexyl-3-hydroxyhexadecanoic Acid (Orlistat Impurity) Anbieter Lieferant Produzent Hersteller Vertrieb Händler.
Global( 47)Lieferanten
130793-28-1()Verwandte Suche:
- N-ForMyl-L-leucine(1S)-1-[(2S,3S)-2-hydroxy-3-[(R)-1-phenylethylcarboMoyl)]
nonyl]dodecyl Ester
(Orlistat IMpurity)
- N-ForMyl-L-leucine(1S)-1-[(2S,3S)-2-hydroxy-3-[(R)-1-phenylethylcarboMoyl)]
nonyl]dodecyl-d3 Ester
(Orlistat IMpurity)
- Orlistat Impurity
- (2S,3R,5S)-5-[(N-Formyl-L-leucyl)oxy]-2-hexyl-3-hydroxyhexadecanoic Acid (Orlistat Impurity)
- (2S, 3R, 5S)-5-[(N-ForMyl-L-leucyl)oxy]-2-hexyl-3-hydroxyhexadecanoic acid
- Orlistat Open Ring Impurity (2S,3R,5S)-Isomer
- Orlistat Open Ring Epimer impurity (Orlistat Open Ring (2S,3R,5S)-Isomer)
- orlistat open ring epimer impurity
- Orlistat Impurity 26
- L-Leucine, N-formyl-, (1S)-1-[(2R,3S)-3-carboxy-2-hydroxynonyl]dodecyl ester
- Orlistat open ring epimer
- (2S,3R,5S)-Orlistat Open Ring Impurity
- Orlistat Related Compound ((2S,3R,5S)-5-[(N-Formyl-L-leucyl)oxy]-2-hexyl-3-hydroxyhexadecanoic acid)
- Orlistat USP Related Compound (Orlistat open ring epimer)
- (2S,3S,5S)-5-<<(S)-2-(Formylamino)-4-methylpentanoyl>oxy>-2-hexyl-3-hydroxyhexadecanoic Acid
- Orlistat Open Ring (2S,3R,5S)-Isomer
- (2S,3R,5S)-5-((formyl-L-leucyl)oxy)-2-hexyl-3-hydroxyhexadecanoic acid
- N-Formyl-L-leucine (1S)-1-[(2R,3S)-3-Carboxy-2-hydroxynonyl]dodecyl Ester
- (2S,3S,5S)-5-[[(S)-2-(Formylamino)-4-methylpentanoyl]oxy]-2-hexyl-3-hydroxyhexadecanoicAci
- Orlistat Impurity 38 (Orlistat Open Ring Epimer)
- Orlistat Impurity 38 (orlistat open-loop differential isomer)
- 130793-28-1
- Amino Acids & Derivatives
- Chiral Reagents
- Impurities
- Intermediates & Fine Chemicals
- Pharmaceuticals